We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.36B
AUM Growth
+$77.6M
Cap. Flow
+$46.1M
Cap. Flow %
3.39%
Top 10 Hldgs %
13.88%
Holding
1,633
New
514
Increased
325
Reduced
386
Closed
373

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$14.2M
2
DOMO icon
Domo
DOMO
+$12.7M
3
NFLX icon
Netflix
NFLX
+$12.4M
4
EA
Electronic Arts
EA
+$12.3M
5
DAY
Dayforce
DAY
+$11.5M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$17.1M
2
COOP
Mr. Cooper
COOP
+$13.5M
3
K
Kellanova
K
+$11.9M
4
LITE icon
Lumentum
LITE
+$9.69M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$9.44M

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Healthcare 13.54%
3 Communication Services 10.55%
4 Consumer Discretionary 9.61%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHL icon
1526
CALL
Scholastic
SCHL
$807M
-795
Closed -$225K
SCHL icon
1527
Scholastic
SCHL
$807M
-72,676
Closed -$1.99M
SCS
1528
DELISTED
Steelcase
SCS
-174,962
Closed -$3.01M
SFM icon
1529
Sprouts Farmers Market
SFM
$7.96B
-6,339
Closed -$690K
SIGA icon
1530
SIGA Technologies
SIGA
$210M
-19,700
Closed -$180K
SIGI icon
1531
Selective Insurance
SIGI
$5.66B
-2,468
Closed -$200K
SITE icon
1532
SiteOne Landscape Supply
SITE
$4.34B
-1,856
Closed -$239K
SLDP icon
1533
Solid Power
SLDP
$536M
-29,400
Closed -$102K
SNDR icon
1534
Schneider National
SNDR
$6.18B
-16,405
Closed -$347K
SNDX icon
1535
Syndax Pharmaceuticals
SNDX
$1.82B
-32,739
Closed -$504K
SNPS icon
1536
Synopsys
SNPS
$78.8B
-1,009
Closed -$498K
SOFI icon
1537
SoFi Technologies
SOFI
$23.4B
-15,216
Closed -$402K
SPLV icon
1538
Invesco S&P 500 Low Volatility ETF
SPLV
$7.17B
-33,004
Closed -$2.43M
SPNS
1539
DELISTED
Sapiens International
SPNS
-12,442
Closed -$535K
SPR
1540
DELISTED
Spirit AeroSystems
SPR
-88,311
Closed -$3.41M
SPY icon
1541
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
-1,162
Closed -$485K
SRAD icon
1542
Sportradar
SRAD
$3.95B
-9,169
Closed -$247K
SRDX
1543
DELISTED
Surmodics
SRDX
-56,018
Closed -$1.67M
STXS icon
1544
Stereotaxis
STXS
$143M
-17,394
Closed -$54.1K
TAL icon
1545
TAL Education Group
TAL
$6.93B
-12,683
Closed -$142K
TARA icon
1546
Protara Therapeutics
TARA
$231M
-21,516
Closed -$93.6K
TCBI icon
1547
Texas Capital Bancshares
TCBI
$4.32B
-2,649
Closed -$224K
TFPM icon
1548
Triple Flag Precious Metals
TFPM
$6.59B
-15,014
Closed -$439K
TMV icon
1549
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$195M
-80,240
Closed -$2.81M
TNDM icon
1550
Tandem Diabetes Care
TNDM
$1.59B
-18,754
Closed -$228K

Similar funds

Prelude Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Prelude Capital Management held 1,633 positions worth $1.36B, up 6.1% from $1.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $46.1M of net new capital in Q4 2025, opening 514 new positions and adding to 325 existing holdings. Its largest new stake was Nice: 117,600 shares worth $13.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lumentum, an estimated $9.69M trimmed.

  • Prelude Capital Management's largest Q4 2025 buy was Nice: 117,600 shares worth $13.3M.
  • Prelude Capital Management added most to Domo in Q4 2025, an estimated $12.7M increase.
  • Prelude Capital Management's biggest Q4 2025 reduction was Lumentum, cutting an estimated $9.69M.
  • Prelude Capital Management fully exited Verona Pharma in Q4 2025, selling an estimated $17.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.36B portfolio in Q4 2025.
  • Prelude Capital Management opened 514 new positions and closed 373 in Q4 2025.
  • Prelude Capital Management's portfolio value rose 6.1% quarter-over-quarter to $1.36B.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.